 Jessica Rove
Concepts (236)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart Transplantation | 7 | 2024 | 736 | 2.320 |
Why?
| | Cardiac Surgical Procedures | 5 | 2024 | 609 | 2.010 |
Why?
| | Tissue and Organ Procurement | 6 | 2024 | 346 | 1.440 |
Why?
| | Extracorporeal Membrane Oxygenation | 5 | 2023 | 383 | 1.070 |
Why?
| | Educational Personnel | 1 | 2022 | 11 | 0.750 |
Why?
| | Thoracic Surgery | 2 | 2024 | 144 | 0.750 |
Why?
| | Lidocaine | 1 | 2022 | 54 | 0.730 |
Why?
| | Gelatin | 1 | 2022 | 56 | 0.720 |
Why?
| | Surgeons | 2 | 2024 | 339 | 0.710 |
Why?
| | Mitral Valve Insufficiency | 1 | 2022 | 72 | 0.690 |
Why?
| | Heart Valve Prosthesis | 1 | 2023 | 134 | 0.690 |
Why?
| | Vascular Grafting | 1 | 2020 | 15 | 0.650 |
Why?
| | Phospholipases A2, Secretory | 4 | 2019 | 14 | 0.610 |
Why?
| | General Surgery | 1 | 2022 | 207 | 0.610 |
Why?
| | Heart Valve Prosthesis Implantation | 1 | 2022 | 197 | 0.600 |
Why?
| | Echocardiography | 1 | 2022 | 652 | 0.590 |
Why?
| | Perfusion | 5 | 2024 | 250 | 0.570 |
Why?
| | Esophageal Neoplasms | 3 | 2017 | 347 | 0.520 |
Why?
| | Stomach Diseases | 1 | 2017 | 20 | 0.510 |
Why?
| | Anastomosis, Surgical | 1 | 2017 | 157 | 0.490 |
Why?
| | Organ Preservation | 4 | 2024 | 130 | 0.480 |
Why?
| | Esophagectomy | 1 | 2017 | 135 | 0.470 |
Why?
| | Deglutition Disorders | 1 | 2017 | 147 | 0.450 |
Why?
| | Enzyme Inhibitors | 4 | 2013 | 824 | 0.450 |
Why?
| | Coronary Artery Disease | 2 | 2020 | 741 | 0.440 |
Why?
| | Stress Disorders, Post-Traumatic | 1 | 2023 | 893 | 0.430 |
Why?
| | Cognition | 1 | 2023 | 1266 | 0.430 |
Why?
| | Reoperation | 1 | 2017 | 630 | 0.410 |
Why?
| | Internship and Residency | 2 | 2020 | 1257 | 0.390 |
Why?
| | Group II Phospholipases A2 | 2 | 2012 | 10 | 0.380 |
Why?
| | Humans | 43 | 2024 | 144759 | 0.370 |
Why?
| | Cardiovascular Diseases | 2 | 2024 | 2168 | 0.350 |
Why?
| | Lung Neoplasms | 5 | 2019 | 2637 | 0.340 |
Why?
| | Quality of Life | 1 | 2023 | 3185 | 0.320 |
Why?
| | Retrospective Studies | 12 | 2024 | 17066 | 0.320 |
Why?
| | Bronchiectasis | 2 | 2012 | 112 | 0.310 |
Why?
| | Pneumonectomy | 2 | 2012 | 169 | 0.300 |
Why?
| | Heart | 2 | 2023 | 636 | 0.300 |
Why?
| | Carcinoma, Non-Small-Cell Lung | 3 | 2012 | 1180 | 0.300 |
Why?
| | Postoperative Complications | 2 | 2017 | 2919 | 0.280 |
Why?
| | Tissue Donors | 4 | 2024 | 424 | 0.280 |
Why?
| | Apoptosis | 4 | 2013 | 2430 | 0.270 |
Why?
| | NF-kappa B | 5 | 2012 | 661 | 0.270 |
Why?
| | Mycobacterium Infections, Nontuberculous | 2 | 2012 | 366 | 0.250 |
Why?
| | Lung Transplantation | 2 | 2024 | 338 | 0.240 |
Why?
| | Osteogenesis | 2 | 2012 | 208 | 0.240 |
Why?
| | United States | 7 | 2024 | 15966 | 0.240 |
Why?
| | Brain Death | 2 | 2024 | 60 | 0.240 |
Why?
| | Intercellular Adhesion Molecule-1 | 3 | 2019 | 138 | 0.230 |
Why?
| | Thoracic Surgical Procedures | 2 | 2024 | 94 | 0.230 |
Why?
| | Adult | 13 | 2024 | 40449 | 0.230 |
Why?
| | Consensus | 2 | 2024 | 488 | 0.230 |
Why?
| | Aortic Valve Stenosis | 2 | 2012 | 253 | 0.220 |
Why?
| | Aortic Valve | 2 | 2012 | 365 | 0.220 |
Why?
| | Cell Proliferation | 3 | 2013 | 2496 | 0.220 |
Why?
| | Adenocarcinoma | 3 | 2013 | 928 | 0.220 |
Why?
| | Treatment Outcome | 7 | 2022 | 11679 | 0.210 |
Why?
| | RNA Interference | 2 | 2012 | 476 | 0.200 |
Why?
| | Organ Preservation Solutions | 1 | 2023 | 47 | 0.200 |
Why?
| | Tissue and Organ Harvesting | 1 | 2024 | 73 | 0.200 |
Why?
| | Primary Graft Dysfunction | 1 | 2023 | 35 | 0.200 |
Why?
| | Physicians, Women | 1 | 2024 | 88 | 0.190 |
Why?
| | Time Factors | 6 | 2024 | 7173 | 0.190 |
Why?
| | Biglycan | 1 | 2012 | 3 | 0.190 |
Why?
| | Travel | 1 | 2023 | 136 | 0.190 |
Why?
| | Coronary Artery Bypass | 2 | 2024 | 268 | 0.190 |
Why?
| | American Heart Association | 1 | 2024 | 350 | 0.180 |
Why?
| | Hernia, Inguinal | 1 | 2012 | 43 | 0.180 |
Why?
| | Herniorrhaphy | 1 | 2012 | 74 | 0.180 |
Why?
| | Jugular Veins | 1 | 2012 | 42 | 0.180 |
Why?
| | Technology Transfer | 1 | 2021 | 9 | 0.180 |
Why?
| | Gene Knockdown Techniques | 1 | 2012 | 336 | 0.170 |
Why?
| | Spinal Cord Ischemia | 1 | 2022 | 60 | 0.170 |
Why?
| | Echocardiography, Transesophageal | 1 | 2022 | 133 | 0.170 |
Why?
| | ras Proteins | 1 | 2012 | 150 | 0.170 |
Why?
| | Periodicals as Topic | 1 | 2024 | 203 | 0.170 |
Why?
| | Toll-Like Receptor 2 | 1 | 2012 | 126 | 0.170 |
Why?
| | Hypothermia, Induced | 1 | 2022 | 96 | 0.170 |
Why?
| | Mitral Valve | 1 | 2022 | 96 | 0.170 |
Why?
| | Multicenter Studies as Topic | 1 | 2023 | 405 | 0.170 |
Why?
| | Death | 1 | 2022 | 130 | 0.170 |
Why?
| | Pulmonary Valve Insufficiency | 1 | 2012 | 48 | 0.170 |
Why?
| | Thoracotomy | 2 | 2017 | 83 | 0.170 |
Why?
| | Computed Tomography Angiography | 1 | 2022 | 145 | 0.170 |
Why?
| | Graft Survival | 1 | 2023 | 526 | 0.170 |
Why?
| | Thoracic Surgery, Video-Assisted | 1 | 2011 | 48 | 0.160 |
Why?
| | Aortic Aneurysm, Thoracic | 1 | 2022 | 139 | 0.160 |
Why?
| | Bronchi | 1 | 2012 | 267 | 0.160 |
Why?
| | Calcinosis | 1 | 2012 | 234 | 0.160 |
Why?
| | Genetic Therapy | 1 | 2012 | 313 | 0.160 |
Why?
| | Coronary Circulation | 1 | 2020 | 136 | 0.160 |
Why?
| | Shock, Cardiogenic | 1 | 2020 | 64 | 0.160 |
Why?
| | Graft Rejection | 1 | 2023 | 540 | 0.150 |
Why?
| | Phosphorylation | 5 | 2013 | 1732 | 0.150 |
Why?
| | Blotting, Western | 5 | 2013 | 1187 | 0.150 |
Why?
| | Ventricular Dysfunction, Right | 1 | 2022 | 248 | 0.150 |
Why?
| | Seizures | 1 | 2023 | 460 | 0.150 |
Why?
| | Blood Vessel Prosthesis Implantation | 1 | 2022 | 228 | 0.150 |
Why?
| | Transcatheter Aortic Valve Replacement | 1 | 2021 | 152 | 0.150 |
Why?
| | Blood Flow Velocity | 1 | 2020 | 413 | 0.150 |
Why?
| | Proto-Oncogene Proteins | 1 | 2012 | 623 | 0.150 |
Why?
| | Heart Arrest | 1 | 2022 | 407 | 0.140 |
Why?
| | Mitogen-Activated Protein Kinase 3 | 2 | 2013 | 138 | 0.140 |
Why?
| | Dinoprostone | 1 | 2019 | 178 | 0.140 |
Why?
| | Mitogen-Activated Protein Kinase 1 | 2 | 2013 | 175 | 0.140 |
Why?
| | Phylogeny | 1 | 2022 | 1016 | 0.130 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2024 | 1720 | 0.130 |
Why?
| | Health Personnel | 1 | 2024 | 748 | 0.130 |
Why?
| | Respiratory Insufficiency | 1 | 2021 | 326 | 0.130 |
Why?
| | Mental Health | 1 | 2024 | 790 | 0.130 |
Why?
| | Carcinoma, Squamous Cell | 1 | 2012 | 641 | 0.130 |
Why?
| | Cell Movement | 1 | 2012 | 965 | 0.130 |
Why?
| | Gastric Emptying | 1 | 2017 | 36 | 0.130 |
Why?
| | Antineoplastic Agents | 2 | 2012 | 2194 | 0.120 |
Why?
| | Laparotomy | 1 | 2017 | 112 | 0.120 |
Why?
| | Delivery of Health Care | 1 | 2023 | 947 | 0.120 |
Why?
| | Critical Illness | 1 | 2023 | 891 | 0.120 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 3 | 2012 | 983 | 0.120 |
Why?
| | Cell Line, Tumor | 5 | 2012 | 3540 | 0.120 |
Why?
| | Neoplasm Proteins | 1 | 2019 | 442 | 0.120 |
Why?
| | Hospital Mortality | 1 | 2020 | 1030 | 0.110 |
Why?
| | Anxiety | 1 | 2023 | 1109 | 0.110 |
Why?
| | Hydrogels | 1 | 2022 | 700 | 0.110 |
Why?
| | Aged | 8 | 2024 | 25913 | 0.110 |
Why?
| | Asphyxia | 1 | 2014 | 23 | 0.110 |
Why?
| | Heart Defects, Congenital | 1 | 2012 | 914 | 0.100 |
Why?
| | Registries | 1 | 2021 | 2385 | 0.090 |
Why?
| | Clinical Competence | 1 | 2020 | 1244 | 0.090 |
Why?
| | Thoracoscopy | 2 | 2012 | 62 | 0.090 |
Why?
| | Middle Aged | 8 | 2024 | 35875 | 0.090 |
Why?
| | Veterans | 1 | 2024 | 1603 | 0.090 |
Why?
| | Mutation | 1 | 2012 | 4089 | 0.080 |
Why?
| | Radiation Injuries | 1 | 2012 | 151 | 0.080 |
Why?
| | Organ Transplantation | 2 | 2024 | 247 | 0.080 |
Why?
| | Dose-Response Relationship, Drug | 3 | 2012 | 2027 | 0.080 |
Why?
| | Male | 11 | 2024 | 72315 | 0.080 |
Why?
| | Transfection | 2 | 2012 | 940 | 0.080 |
Why?
| | RNA, Messenger | 3 | 2012 | 2832 | 0.080 |
Why?
| | Aorta, Thoracic | 2 | 2022 | 286 | 0.080 |
Why?
| | Mice | 2 | 2022 | 18339 | 0.070 |
Why?
| | Bone Morphogenetic Protein 2 | 2 | 2012 | 77 | 0.070 |
Why?
| | Alkaline Phosphatase | 2 | 2012 | 145 | 0.070 |
Why?
| | Female | 9 | 2024 | 78271 | 0.070 |
Why?
| | Surveys and Questionnaires | 1 | 2020 | 6048 | 0.070 |
Why?
| | Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2011 | 439 | 0.070 |
Why?
| | Patient Selection | 2 | 2012 | 719 | 0.070 |
Why?
| | Animals | 3 | 2022 | 38058 | 0.060 |
Why?
| | Databases, Factual | 2 | 2020 | 1486 | 0.060 |
Why?
| | Cell Survival | 2 | 2012 | 1098 | 0.050 |
Why?
| | Aged, 80 and over | 3 | 2021 | 8265 | 0.050 |
Why?
| | Raffinose | 1 | 2023 | 29 | 0.050 |
Why?
| | Allopurinol | 1 | 2023 | 69 | 0.050 |
Why?
| | Donor Selection | 1 | 2024 | 79 | 0.050 |
Why?
| | Costs and Cost Analysis | 1 | 2024 | 219 | 0.050 |
Why?
| | Shock | 1 | 2024 | 108 | 0.050 |
Why?
| | Cell Growth Processes | 1 | 2012 | 50 | 0.050 |
Why?
| | Circulatory Arrest, Deep Hypothermia Induced | 1 | 2022 | 26 | 0.050 |
Why?
| | Surgical Mesh | 1 | 2012 | 50 | 0.050 |
Why?
| | Ki-67 Antigen | 1 | 2012 | 117 | 0.050 |
Why?
| | Paraplegia | 1 | 2022 | 61 | 0.050 |
Why?
| | Lipoproteins, LDL | 1 | 2012 | 119 | 0.040 |
Why?
| | Adenosine | 1 | 2023 | 255 | 0.040 |
Why?
| | Signal Transduction | 3 | 2013 | 5226 | 0.040 |
Why?
| | Glutathione | 1 | 2023 | 375 | 0.040 |
Why?
| | Workplace | 1 | 2024 | 274 | 0.040 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 1 | 2012 | 173 | 0.040 |
Why?
| | Airway Management | 1 | 2012 | 79 | 0.040 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 1 | 2012 | 266 | 0.040 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2012 | 269 | 0.040 |
Why?
| | Blood Vessel Prosthesis | 1 | 2022 | 140 | 0.040 |
Why?
| | Proto-Oncogene Proteins p21(ras) | 1 | 2012 | 253 | 0.040 |
Why?
| | Tumor Burden | 1 | 2012 | 319 | 0.040 |
Why?
| | Occupational Health | 1 | 2024 | 209 | 0.040 |
Why?
| | Secondary Prevention | 1 | 2012 | 254 | 0.040 |
Why?
| | Mice, Nude | 1 | 2012 | 682 | 0.040 |
Why?
| | Organ Size | 1 | 2012 | 463 | 0.040 |
Why?
| | Cells, Cultured | 2 | 2012 | 4154 | 0.040 |
Why?
| | Vascular Patency | 1 | 2020 | 121 | 0.040 |
Why?
| | Toll-Like Receptor 4 | 1 | 2012 | 276 | 0.040 |
Why?
| | Microscopy, Fluorescence | 1 | 2012 | 416 | 0.040 |
Why?
| | Down-Regulation | 1 | 2012 | 627 | 0.040 |
Why?
| | Antitubercular Agents | 1 | 2012 | 215 | 0.040 |
Why?
| | Neoplasm Invasiveness | 1 | 2012 | 508 | 0.040 |
Why?
| | Cerebrovascular Circulation | 1 | 2022 | 280 | 0.040 |
Why?
| | Syndrome | 1 | 2011 | 380 | 0.040 |
Why?
| | Molecular Targeted Therapy | 1 | 2012 | 432 | 0.040 |
Why?
| | Xenograft Model Antitumor Assays | 1 | 2012 | 928 | 0.040 |
Why?
| | United States Department of Veterans Affairs | 1 | 2024 | 768 | 0.040 |
Why?
| | Cattle | 1 | 2012 | 1000 | 0.040 |
Why?
| | Analysis of Variance | 1 | 2012 | 1306 | 0.040 |
Why?
| | Antibodies, Neutralizing | 1 | 2012 | 340 | 0.040 |
Why?
| | A549 Cells | 1 | 2019 | 75 | 0.040 |
Why?
| | Postoperative Care | 1 | 2011 | 288 | 0.040 |
Why?
| | Anesthesia | 1 | 2012 | 258 | 0.040 |
Why?
| | Neoplasm Staging | 1 | 2012 | 1462 | 0.030 |
Why?
| | Glucose | 1 | 2023 | 1047 | 0.030 |
Why?
| | Survivors | 1 | 2022 | 520 | 0.030 |
Why?
| | Pilot Projects | 1 | 2024 | 1886 | 0.030 |
Why?
| | Stents | 1 | 2022 | 556 | 0.030 |
Why?
| | Risk | 1 | 2020 | 911 | 0.030 |
Why?
| | Burnout, Professional | 1 | 2024 | 484 | 0.030 |
Why?
| | STAT3 Transcription Factor | 1 | 2019 | 207 | 0.030 |
Why?
| | Biomarkers | 2 | 2012 | 4271 | 0.030 |
Why?
| | Multivariate Analysis | 1 | 2020 | 1539 | 0.030 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2012 | 1455 | 0.030 |
Why?
| | Intensive Care Units | 1 | 2022 | 916 | 0.030 |
Why?
| | Comorbidity | 1 | 2020 | 1658 | 0.030 |
Why?
| | Lung Diseases | 1 | 2012 | 787 | 0.030 |
Why?
| | Case-Control Studies | 1 | 2012 | 3604 | 0.030 |
Why?
| | Prognosis | 1 | 2012 | 4282 | 0.020 |
Why?
| | Age Factors | 1 | 2020 | 3333 | 0.020 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2020 | 920 | 0.020 |
Why?
| | Osteopontin | 1 | 2012 | 34 | 0.020 |
Why?
| | Core Binding Factor Alpha 1 Subunit | 1 | 2012 | 45 | 0.020 |
Why?
| | Insulin | 1 | 2023 | 2507 | 0.020 |
Why?
| | Pravastatin | 1 | 2011 | 43 | 0.020 |
Why?
| | Body Mass Index | 1 | 2020 | 2438 | 0.020 |
Why?
| | Heptanoic Acids | 1 | 2011 | 67 | 0.020 |
Why?
| | Hypertension | 1 | 2020 | 1263 | 0.020 |
Why?
| | Radiotherapy | 1 | 2012 | 206 | 0.020 |
Why?
| | Simvastatin | 1 | 2011 | 60 | 0.020 |
Why?
| | Tumor Cells, Cultured | 1 | 2013 | 919 | 0.020 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2013 | 436 | 0.020 |
Why?
| | Cohort Studies | 1 | 2021 | 5960 | 0.020 |
Why?
| | Tomography, X-Ray Computed | 1 | 2011 | 2730 | 0.020 |
Why?
| | Pyrroles | 1 | 2011 | 217 | 0.020 |
Why?
| | Adolescent | 2 | 2023 | 22428 | 0.020 |
Why?
| | Up-Regulation | 1 | 2012 | 851 | 0.020 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2013 | 1217 | 0.020 |
Why?
| | Flow Cytometry | 1 | 2011 | 1173 | 0.020 |
Why?
| | Infant | 1 | 2012 | 10034 | 0.020 |
Why?
| | Child, Preschool | 1 | 2012 | 11787 | 0.020 |
Why?
| | Suicide | 1 | 2014 | 720 | 0.020 |
Why?
| | Phenotype | 1 | 2012 | 3162 | 0.010 |
Why?
| | Child | 1 | 2012 | 22633 | 0.010 |
Why?
| | Young Adult | 1 | 2014 | 14105 | 0.010 |
Why?
|
|
Rove's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|